Latest News in the pharma Industry

Biopharma News

PhoreMost Ltd Founded to Identify New Druggable Targets for Therapeutics

PhoreMost Ltd Founded to Identify New Druggable Targets for Therapeutics

7 Apr 2015

Read more 
Cobra Biologics and Tecrea Awarded £112K Innovate UK Grant to Develop AAV Scalable Production Bioprocess

Cobra Biologics and Tecrea Awarded £112K Innovate UK Grant to Develop AAV Scalable Production Bioprocess

1 Apr 2015

Read more 
Hospira's Proposed Biosimilar, Epoetin Hospira, Demonstrates PK/PD Equivalence Compared to Amgen's Epogen

Hospira's Proposed Biosimilar, Epoetin Hospira, Demonstrates PK/PD Equivalence Compared to Amgen's Epogen

30 Mar 2015

Read more 
Amgen Submits Application for Investigational LDL Cholesterol-Lowering Medication Repatha in Japan

Amgen Submits Application for Investigational LDL Cholesterol-Lowering Medication Repatha in Japan

25 Mar 2015

Read more 
Rentschler Commissions New 2000-L Single-Use Bioreactor

Rentschler Commissions New 2000-L Single-Use Bioreactor

23 Mar 2015

Read more 
BASF and Eight Partners Cooperate to Optimize Production Processes for Renewable-Based Products

BASF and Eight Partners Cooperate to Optimize Production Processes for Renewable-Based Products

19 Mar 2015

Read more 
Catalent Announces New Organisation to Speed New Products to Market

Catalent Announces New Organisation to Speed New Products to Market

17 Mar 2015

Read more 
China’s BeiGene Selects SAFC CHOZN Platform for Commercial Drug Development

China’s BeiGene Selects SAFC CHOZN Platform for Commercial Drug Development

12 Mar 2015

Read more 
FDA Approves First Biosimilar Zarxio (Filgrastim-sndz) from Sandoz

FDA Approves First Biosimilar Zarxio (Filgrastim-sndz) from Sandoz

10 Mar 2015

Read more 
Hospira Statement on FDA Approval of the First Biosimilar in the US

Hospira Statement on FDA Approval of the First Biosimilar in the US

6 Mar 2015

Read more 
JSR Corp. and KBI Biopharma Agree to Acquisition; INCJ and CMIC of Japan also Participate

JSR Corp. and KBI Biopharma Agree to Acquisition; INCJ and CMIC of Japan also Participate

5 Mar 2015

Read more 
FDA Accepts sBLA for Yervoy as Adjuvant Treatment for Patients with Stage 3 Melanoma

FDA Accepts sBLA for Yervoy as Adjuvant Treatment for Patients with Stage 3 Melanoma

3 Mar 2015

Read more